กำลังโหลด
NASDAQHealthcareMedical - Diagnostics & Research
ข้อมูลล่าสุด
US$164.5
+US$0.42 · +0.26%
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ราคาปิดก่อนหน้า
US$164.5
+US$0.42 · +0.26%
หลังปิดตลาด
US$164.5
US$0.00 · 0.00%
8 ต.ค. 19:30 ET
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ช่วงราคารายวัน
ปัจจุบัน US$164.5
ช่วง 52 สัปดาห์
ปัจจุบัน US$164.5
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ถือ
มูลค่า
79
ต่ำกว่ามูลค่า
ความเชื่อมั่น
54
ผสม
ความเสี่ยง
50
ความเสี่ยงค่อนข้างสูง
โมเมนตัม
51
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ช่วงราคารายวัน
ปัจจุบัน US$164.5
ช่วง 52 สัปดาห์
ปัจจุบัน US$164.5
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
U.S. Small Cap Value Portfolio ETF Class SharesDFSV118.38M0.44%26.69B USD0.33%US$38.10+0.82%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH98.63M0.21%145.5M USD0.25%US$49.84+0.03%
Dimensional - US Targeted Value ETFDFAT36.67M0.12%30B USD0.33%US$67.56+0.72%
Principal Exchange-Traded Funds - Principal International Equity ETFPIEQ25.96M1.94%1.3B USD0.48%US$35.39-0.84%
Dimensional - US Core Equity 2 ETFDFAC21.36M0.02%88.28B USD0.21%US$45.11-0.15%
Dimensional - US Small Cap ETFDFAS19.04M0.06%33.66B USD0.31%US$78.10+0.23%
State Street SPDR Portfolio Developed World ex-US ETFSPDW16.2M0.04%40.77B USD0.03%US$49.66-0.58%
Thrivent Small-Mid Cap Equity ETFTSME14.44M1.61%895.7M USD0.65%US$46.29-0.96%U.S. Small Cap Value Portfolio ETF Class SharesDFSVGuggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSHDimensional - US Targeted Value ETFDFATPrincipal Exchange-Traded Funds - Principal International Equity ETFPIEQDimensional - US Core Equity 2 ETFDFACDimensional - US Small Cap ETFDFASState Street SPDR Portfolio Developed World ex-US ETFSPDWThrivent Small-Mid Cap Equity ETFTSMEเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน
